PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC

Clinical trial NCT05737563 · UNKNOWN

Trial details

NCT number: NCT05737563
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Abdominal Stage 0

Start date: 2023-02-17
Primary completion: 2026-02-17
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.